Search - tctmd.com

Displaying 41 - 60 of 60

Sort: Relevancy | Date

News Daily News

Los 10 Artículos Más Populares de TCTMD de 2011

Jason Kahn

March 08, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

Jason Kahn

March 05, 2012

News Daily News

No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel

Jason Kahn

February 12, 2012

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Conference News

Different Agents Show Potential as Adjuncts to PCI

Jason Kahn

May 19, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn

April 21, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Jason Kahn

April 11, 2011

News Daily News

Sponsors Pull the Plug on TRIGGER-PCI

Jason Kahn

March 18, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

News Daily News

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

Jason Kahn

February 02, 2011

News Daily News

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

Jason Kahn

January 26, 2011

News Daily News

Researchers Accurately Predict Who Will Discontinue Clopidogrel

Jason Kahn

January 09, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

Advertisement

Los 10 Artículos Más Populares de TCTMD de 2011

Statins Reduce Late Restenosis After SES Implantation

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Six Months Sufficient for Dual Antiplatelet Therapy

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Different Agents Show Potential as Adjuncts to PCI

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Sponsors Pull the Plug on TRIGGER-PCI

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Late Aspirin Use Before CABG Does Not Increase Ischemic Events

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

Researchers Accurately Predict Who Will Discontinue Clopidogrel

TCTMD’s Top 10 Most Popular News Stories for 2010

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content